Valuation: Incyte Corporation

Market Cap 24.44B 21.14B 19.74B 18.11B 34.06B 2,326B 34.6B 232B 90.9B 1,166B 91.77B 89.76B 3,854B P/E 2026 *
53.8x
P/E 2027 * 16.8x
Enterprise Value 20.19B 17.46B 16.31B 14.96B 28.14B 1,921B 28.58B 191B 75.1B 963B 75.81B 74.15B 3,184B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.98x
Free-Float
98.14%
Yield 2026 *
-
Yield 2027 * -
1 day+1.84%
1 week+0.87%
Current month+0.87%
1 month+2.13%
3 months+23.31%
6 months+11.23%
Current year+22.06%
1 week 115.77
Extreme 115.77
124.57
1 month 110.56
Extreme 110.56
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 78.2
Extreme 78.2
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
3/8/26 Fiscal year

EVP & Chief Scientific Officer

18,165 0.0091%
31/7/26 Sell

Chairperson

-15,888 0.0080%
23/7/26 Free

Chief Technology Officer

15,425 0.0077%
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%+0.87%+54.17%+85.73% 24.44B
+1.59%+2.85%+40.11%+1.24% 78.32B
+2.77%+4.78%-1.65%+27.62% 51.1B
-0.84%+0.09%+20.92%+179.15% 49.18B
-0.13%+7.42%-50.22%-49.58% 44.71B
+0.80%+2.46%+62.77%-23.33% 30.72B
+9.86%+7.94%+122.36%-41.53% 23.62B
+4.29%+9.40%+3.77%+226.51% 21.05B
+1.66%-3.70%+65.40%+123.91% 16.61B
+2.03%+5.48%+83.85%+172.87% 16.51B
Average +2.39%+4.22%+40.15%+70.26% 35.63B
Weighted average by Cap. +1.89%+4.35%+29.57%+51.03%

Financials

2026 *2027 *
Net sales 5.94B 5.14B 4.8B 4.4B 8.28B 566B 8.41B 56.32B 22.11B 283B 22.32B 21.83B 937B 6.26B 5.41B 5.05B 4.64B 8.72B 595B 8.86B 59.28B 23.27B 298B 23.49B 22.98B 986B
Net income 466M 403M 376M 345M 649M 44.31B 659M 4.41B 1.73B 22.21B 1.75B 1.71B 73.43B 1.47B 1.27B 1.19B 1.09B 2.05B 140B 2.08B 13.94B 5.47B 70.14B 5.52B 5.4B 232B
Net Debt -4.25B -3.68B -3.43B -3.15B -5.92B -404B -6.02B -40.27B -15.81B -203B -15.96B -15.61B -670B -5.81B -5.03B -4.69B -4.31B -8.1B -553B -8.23B -55.08B -21.62B -277B -21.83B -21.35B -917B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
07/08/26 USD 120.56 +1.84% 1,540,373
06/08/26 USD 118.38 -1.19% 2,390,460
05/08/26 USD 119.80 -0.66% 1,795,673
04/08/26 USD 120.60 +1.83% 2,077,654
03/08/26 USD 118.43 -0.91% 1,419,133
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
120.56USD
Average target price
124.96USD
Spread / Average Target
+3.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock